1st Circ. Hints Insys Execs' Convictions Will Stand

Law360 (May 6, 2021, 5:16 PM EDT) -- Emotional patient testimony and a prosecutor's improper remark during closing arguments likely aren't enough to overturn a landmark verdict convicting five former Insys Therapeutics executives of a scheme to bribe doctors to prescribe opioids, a First Circuit panel suggested Thursday.

The panel heard nearly two hours of oral arguments in the appeals of Insys Therapeutics Inc. founder John Kapoor and former underlings Michael Gurry, Rich Simon, Joe Rowan and Sunrise Lee, as well as the government's bid to reinstate part of the racketeering conviction that was thrown out by the trial judge.

Kapoor's attorney, Martin G. Weinberg of Martin G. Weinberg...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!